Key result
Intradialytic hypertension occurs in approximately 10% of hemodialysis patients and is associated with increased hospitalization and mortality, with fluid removal remaining the key treatment.
Intradialytic hypertension is a significant complication in hemodialysis patients driven by fluid overload and hemodynamic changes, requiring fluid removal as the primary treatment.
Answers are grounded in this paper and cite their sources.
Warrants vigilance for intradialytic hypertension in hemodialysis; leaves open optimal strategies beyond fluid removal pending prospective trials.
Intradialytic hypertension (IDH) is defined by blood pressure (BP) values during and at the end of the dialysis session exceeding BP values at dialysis onset. It occurs in around 10% of hemodialysis (HD) patients. It is associated with HD patients' hospitalization and increased risk of death. Many hypotheses have been proposed to explain this phenomenon. Recent studies and reports highlight the important role of fluid overload, hemodynamic changes, and increased endothelin level. The importance of other hypotheses such as the renin-angiotensin system activation, sympathetic overactivity and ionic variations seems secondary but it deserves to be confirmed. Fluid removal remains the key point for treating IDH. Several important unanswered questions remain and the need for further research is highlighted.
No takes yet. Share an insight, caveat, or question.
Chazot et al. (2010) conducted a review in Intradialytic hypertension in hemodialysis patients. Fluid removal was evaluated. Intradialytic hypertension occurs in approximately 10% of hemodialysis patients and is associated with increased hospitalization and mortality, with fluid removal remaining the key treatment.
Synapse has enriched 10 related papers. Consider them for comparative context: